Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continuing their series celebrating ‘amazing people at Oxford who you should know about’, Central University's Science Blog talks to Dayne Beccano-Kelly, an electrophysiologist and Career Development Fellow in our department and part of the Oxford Parkinson’s Disease Centre.

With more than ten years’ experience in the field, Dayne discusses his research using human neurons to improve treatments and the quality of life for people with neurodegenerative conditions such as Parkinson’s disease. He also shares how he is aiming to tackle the lack of BAME leadership opportunities in STEM, by mentoring and inspiring black and minority ethnic scientists of tomorrow.

How would you describe your journey to Oxford?

I am from Cardiff originally, and took my undergraduate degree at Leeds University in bio-chemistry, as a route into medicine. But, after my first year, I changed my mind with a stint in research, as part of my year in industry.

Time and experience showed me that what I really wanted to do was science research, helping people, but being the one to garner the knowledge that would help. It is fun to be continually asking the questions, and driving the conversation on known scientific knowledge.

Was Oxford what you expected it to be?

Oxford is a melting pot of scientific ideas that are often brewing a stone’s throw away, which makes it easier to interact with other scientists and develop collaborations.

I have been here four years now and don’t feel marginalised at Oxford. I expected there to be a low number of BAME academics at Oxford, because there have been at every other institution.

Having lived in Vancouver directly before this, which I loved in a different way, I can feel the contrast. It’s great to be surrounded by so much history. Vancouver is younger than Arsenal FC, my football team.

 

Read the full interview on the University of Oxford's Science Blog.

Similar stories

New laboratory space for OPDC Researchers

OPDC News

A major building in the centre of Oxford has been constructed to create a new research centre bringing together cellular neuroscience and physical sciences.

Dopamine neurons need a 'REST' in Parkinson’s Disease

OPDC News

A study led by University of Oxford researchers, Dr Brent Ryan and Dr Nora Bengoa-Vergniory has shown that the key protein RE1 Silencing Transcription Factor (REST) regulates the health of those neurons critically affected in Parkinson’s Disease.

Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease

OPDC News

A study led by the Oxford Parkinson’s Disease Centre’s (OPDC) Dr Nora Bengoa-Vergniory has shown that a novel assay termed the tau-proximity ligation assay is able to recognise Alzheimer’s disease before current detection methods.

Just over half of British Indians would take COVID vaccine

EDI News Outreach Postdoctoral Publication Research Riley Group News

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Lukas Krone to represent Oxford at the Global Young Scientists Summit

Awards and Honours EDI News Head of Department's News Students Vyazovskiy Group News

Congratulations are in order for Dr Lukas Krone who is one of just five University of Oxford researchers selected to attend the Global Young Scientists Summit 2021.